1. Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
   Yiyuan Pan et al, 2018, Cell & Bioscience CrossRef
2. Silencing dishevelled‐1 sensitizes paclitaxel‐resistant human ovarian cancer cells via AKT/GSK‐3β/β‐catenin signalling
   Kun Zhang et al, 2015, Cell Proliferation CrossRef
3. A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients
   Caitlin Phillips-Chavez et al, 2020, European Journal of Clinical Pharmacology CrossRef
4. New approaches for targeting platinum-resistant ovarian cancer
   Michelle McMullen et al, 2021, Seminars in Cancer Biology CrossRef
5. Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
   Joan Tymon-Rosario et al, 2021, Cancers CrossRef
6. Excision Repair Cross-Complementation Group 1 (ERCC1): A Prognostic and Predictive Biomarker in Patients with Colorectal Cancer Receiving Adjuvant Oxaliplatin Based Chemotherapy
   Adel Gabr et al, 2016, Journal of Cancer Therapy CrossRef
7. Overview of a chemoresponse assay in ovarian cancer
   E. C. Grendys et al, 2014, Clinical and Translational Oncology CrossRef
8. Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer
   James Scurry et al, 2018, Gynecologic Oncology CrossRef
9. Functional role of the Tau protein in epithelial ovarian cancer cells
   Aisa Yamauchi et al, 2017, Reproductive Medicine and Biology CrossRef
10. hMSH2 expression is associated with paclitaxel resistance in ovarian carcinoma, and inhibition of hMSH2 expression in vitro restores paclitaxel sensitivity
    JIN ZHANG et al, 2014, Oncology Reports CrossRef
11. Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
    Michelle McMullen et al, 2020, Cancers CrossRef
12. Regulation of human MAPT gene expression
    Marie-Laure Caillet-Boudin et al, 2015, Molecular Neurodegeneration CrossRef
13. Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy
    Mu-Xing Li et al, 2016, Chinese Medical Journal CrossRef
14. Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer
    Sharareh Mokmeli et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
15. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin
    Maria V. Barbolina, 2021, Pharmacological Research CrossRef
16. Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
    Cornelia Schroeder et al, 2019, BMC Cancer CrossRef
17. Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells
    Tiejun Song et al, 2018, Cancer Biomarkers CrossRef
18. Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts
    Federica Guffanti et al, 2020, Cancers CrossRef
19. Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study
    Valentina Karin‐Kujundzic et al, 2020, APMIS CrossRef
20. Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated Protein Tau Implicated in Resistance to Paclitaxel Therapy in Ovarian Carcinoma
    Hilal Gurler et al, 2015, International Journal of Molecular Sciences CrossRef
21. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
    Rayane Hedna et al, 2022, Cancers CrossRef
22. Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients
    Menghuang Zhao et al, 2018, Life Sciences CrossRef
23. ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy
    Aziza E. Abdelrahman et al, 2020, Cancer Biomarkers CrossRef